Access cutting-edge severe asthma treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access severe asthma specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related severe asthma treatment provided free
The purpose of the study is to evaluate effect of benralizumab on structural and lung function changes in severe eosinophilic asthmatics. Changes will be assessed over 48 week treatment period in patients with persistent symptoms despite standard therapy of inhaled corticosteroids (ICS) plus long acting B2-agonist (LABA) with or without additional controller medication. Patients who complete treatment will enter 4 weeks follow-up period.
Sponsor: AstraZeneca
Check if you qualify for this severe asthma clinical trial in Indianapolis, IN
If you're searching for severe asthma treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced severe asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.